Evidence map›Paper›PMID 28475610›Full record

ArticlePloS one2017

An improved method with high sensitivity and low background in detecting low β-galactosidase expression in mouse embryos.

Xiaopeng Shen, Wenjing Bao, Wei Yu, Rui Liang, Bao Nguyen, Yu Liu

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Evidence for Fgf and Wnt regulation ofFrontiers in cell and developmental biology · 2025
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Xiaopeng ShenDepartment of Biology and Biochemistry, University of Houston, Houston, TX, United States of America.
Wenjing BaoDepartment of Medicine, Liaoning University of Traditional Chinese Medicine, Shenyang, China.
Wei YuDepartment of Biology and Biochemistry, University of Houston, Houston, TX, United States of America.
Rui LiangDepartment of Biology and Biochemistry, University of Houston, Houston, TX, United States of America.
Bao NguyenDepartment of Biology and Biochemistry, University of Houston, Houston, TX, United States of America.
Yu LiuDepartment of Biology and Biochemistry, University of Houston, Houston, TX, United States of America.ORCID http://orcid.org/0000-0002-1282-4897
University of Houston · USLiaoning University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

LacZ is widely used as a reporter in studies of gene expression patterns. β-galactosidase, the product of LacZ gene, is usually detected by X-gal/FeCN staining. In X-gal/FeCN staining, β-galactosidase catalyzes X-gal to produce blue precipitates, which indicate the expression patterns of the gene of interest. A newer LacZ detection method using S-gal/TNBT is more sensitive but plagued by high background. Here, we describe an improved procedure that combines advantageous steps from the two methods. By comparing with X-gal/FeCN and S-gal/TNBT methods in detecting the expression patterns of miR-322/503 and miR-451 at a series of developmental stages, the improved method showed higher sensitivity and lower background. Thus, the improved method could be an alternative way of β-galactosidase staining in low gene expression situations.

Indexed as

Animalsbeta-GalactosidaseEmbryo, MammalianFemaleLac OperonLimit of DetectionMaleMiceMice, KnockoutReproducibility of Resultsbeta-Galactosidase

Identifiers

PMID28475610
PMCPMC5419561
OpenAlexW2611948988

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.